While incidence of community-associated and healthcare-associated community-onset MRSA bacteremia declined during the pandemic, hospital-onset cases rose substantially.
A review and meta-analysis found the pooled prevalence of MRSA in low- and middle income countries was 15%—significantly higher than found in Europe and the US.
The case was identified in a nursing home patient in North Carolina, but no transmission was detected.
A population-wide cohort study in Ontario finds that more than 15% of residents colonized with resistant bacteria went on to develop an infection with the same organism.
Pathogens like methicillin-resistant Staphylococcus aureus fell substantially prior to the pandemic, but others increased, and some surged during COVID-19.
Researchers found household exposure to a recently hospitalized family member increased the chances of getting a methicillin-resistant Staphylococcus aureus infection by 44%.
The research team identified Staphylococcus aureus in 3% of animal samples, with 18% of them methicillin-resistant.
The proportion of MRSA isolates declined significantly from 2010 through 2019, but resistance to non–beta-lactam antibiotics rose, particularly in southern states.
The intervention involved use of an antiseptic soap and nasal ointment on patients in a network of hospitals, nursing homes, and long-term care facilities.
Data collected from 29 European countries revealed interactions between age, sex, and resistant bloodstream infections.
